| Year |
Citation |
Score |
| 2023 |
Gibson S, Noronha LE, Tubbs H, Cohnstaedt LW, Wilson WC, Mire C, Mitzel D, Anyamba A, Rostal M, Linthicum KJ. The increasing threat of Rift Valley fever virus globalization: strategic guidance for protection and preparation. Journal of Medical Entomology. PMID 37862067 DOI: 10.1093/jme/tjad113 |
0.411 |
|
| 2023 |
Ronk AJ, Lloyd NM, Zhang M, Atyeo C, Perrett HR, Mire CE, Hastie KM, Sanders RW, Brouwer PJM, Saphire EO, Ward AB, Ksiazek TG, Alvarez Moreno JC, Thaker HM, Alter G, et al. A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection. Nature Communications. 14: 5603. PMID 37699929 DOI: 10.1038/s41467-023-41376-6 |
0.457 |
|
| 2023 |
Mire CE, Satterfield BA, Geisbert TW. Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation. Methods in Molecular Biology (Clifton, N.J.). 2682: 159-173. PMID 37610581 DOI: 10.1007/978-1-0716-3283-3_12 |
0.324 |
|
| 2023 |
Satterfield BA, Mire CE, Geisbert TW. Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection. Methods in Molecular Biology (Clifton, N.J.). 2682: 1-22. PMID 37610570 DOI: 10.1007/978-1-0716-3283-3_1 |
0.312 |
|
| 2023 |
Halfmann PJ, Borisevich V, Levine CB, Mire CE, Fenton KA, Geisbert TW, Kawaoka Y, Cross RW. The Mucin-like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets. The Journal of Infectious Diseases. PMID 37379580 DOI: 10.1093/infdis/jiad240 |
0.4 |
|
| 2022 |
Mears MC, Rodriguez SE, Schmitz KS, Padilla A, Biswas S, Cajimat MNB, Mire CE, Welch SR, Bergeron É, Alabi CA, Porotto M, Bente DA. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus. Antiviral Research. 105401. PMID 36049554 DOI: 10.1016/j.antiviral.2022.105401 |
0.303 |
|
| 2022 |
Ilinykh PA, Periasamy S, Huang K, Kuzmina NA, Ramanathan P, Meyer MN, Mire CE, Kuzmin IV, Bharaj P, Endsley JR, Chikina M, Sealfon SC, Widen SG, Endsley MA, Bukreyev A. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2. Npj Vaccines. 7: 47. PMID 35468973 DOI: 10.1038/s41541-022-00471-3 |
0.36 |
|
| 2021 |
Sorvillo TE, Cross RW, Johnson DM, Dobias NS, Fenton KA, Mire CE, Geisbert TW. Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge. Npj Vaccines. 6: 96. PMID 34373461 DOI: 10.1038/s41541-021-00361-0 |
0.349 |
|
| 2021 |
Malherbe DC, Kurup D, Wirblich C, Ronk AJ, Mire C, Kuzmina N, Shaik N, Periasamy S, Hyde MA, Williams JM, Shi PY, Schnell MJ, Bukreyev A. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. Npj Vaccines. 6: 91. PMID 34294728 DOI: 10.1038/s41541-021-00352-1 |
0.394 |
|
| 2021 |
Dang HV, Cross RW, Borisevich V, Bornholdt ZA, West BR, Chan YP, Mire CE, Da Silva SC, Dimitrov AS, Yan L, Amaya M, Navaratnarajah CK, Zeitlin L, Geisbert TW, Broder CC, et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nature Structural & Molecular Biology. PMID 33927387 DOI: 10.1038/s41594-021-00584-8 |
0.331 |
|
| 2020 |
Woolsey C, Jankeel A, Matassov D, Geisbert JB, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Latham TE, Gerardi CS, Mire CE, Eldridge JH, Messaoudi I, Geisbert TW. Immune correlates of postexposure vaccine protection against Marburg virus. Scientific Reports. 10: 3071. PMID 32080323 DOI: 10.1038/S41598-020-59976-3 |
0.335 |
|
| 2019 |
Prasad AN, Woolsey C, Geisbert JB, Agans KN, Borisevich V, Deer DJ, Mire CE, Cross RW, Fenton KA, Broder CC, Geisbert TW. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity. The Journal of Infectious Diseases. PMID 32022850 DOI: 10.1093/Infdis/Jiz613 |
0.377 |
|
| 2019 |
Cross RW, Xu R, Matassov D, Hamm S, Latham TE, Gerardi CS, Nowak RM, Geisbert JB, Ota-Setlik A, Agans KN, Luckay A, Witko SE, Soukieh L, Deer DJ, Mire CE, et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. The Journal of Clinical Investigation. PMID 31820871 DOI: 10.1172/Jci131958 |
0.334 |
|
| 2019 |
Mire CE, Chan YP, Borisevich V, Cross RW, Yan L, Agans KN, Dang HV, Veesler D, Fenton KA, Geisbert TW, Broder CC. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. PMID 31686101 DOI: 10.1093/Infdis/Jiz515 |
0.405 |
|
| 2019 |
Geisbert JB, Borisevich V, Prasad AN, Agans KN, Foster SL, Deer DJ, Cross RW, Mire CE, Geisbert TW, Fenton KA. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys. The Journal of Infectious Diseases. PMID 31665362 DOI: 10.1093/Infdis/Jiz391 |
0.303 |
|
| 2019 |
Dang HV, Chan YP, Park YJ, Snijder J, Da Silva SC, Vu B, Yan L, Feng YR, Rockx B, Geisbert TW, Mire CE, Broder CC, Veesler D. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nature Structural & Molecular Biology. PMID 31570878 DOI: 10.1038/S41594-019-0308-9 |
0.345 |
|
| 2019 |
Woolsey C, Menicucci AR, Cross RW, Luthra P, Agans KN, Borisevich V, Geisbert JB, Mire CE, Fenton KA, Jankeel A, Anand S, Ebihara H, Geisbert TW, Messaoudi I, Basler CF. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge. Cell Reports. 28: 3032-3046.e6. PMID 31533029 DOI: 10.1016/J.Celrep.2019.08.047 |
0.311 |
|
| 2019 |
Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE. The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus. Iscience. PMID 31402258 DOI: 10.1016/J.Isci.2019.07.003 |
0.406 |
|
| 2019 |
Rodriguez SE, Cross RW, Fenton KA, Bente DA, Mire CE, Geisbert TW. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever. Scientific Reports. 9: 7755. PMID 31123310 DOI: 10.1038/S41598-019-44210-6 |
0.407 |
|
| 2019 |
Mire CE, Geisbert JB, Agans KN, Versteeg KM, Deer DJ, Satterfield BA, Fenton KA, Geisbert TW. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease. Emerging Infectious Diseases. 25: 1144-1152. PMID 31107231 DOI: 10.3201/Eid2506.181620 |
0.369 |
|
| 2019 |
Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host & Microbe. 25: 49-58.e5. PMID 30629918 DOI: 10.1016/J.Chom.2018.12.005 |
0.454 |
|
| 2019 |
Marzi A, Mire CE. Current Ebola Virus Vaccine Progress. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 30604389 DOI: 10.1007/s40259-018-0329-7 |
0.336 |
|
| 2018 |
Gilchuk P, Mire CE, Geisbert JB, Agans KN, Deer DJ, Cross RW, Slaughter JC, Flyak AI, Mani J, Pauly MH, Velasco J, Whaley KJ, Zeitlin L, Geisbert TW, Crowe JE. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates. The Journal of Infectious Diseases. PMID 29982718 DOI: 10.1093/Infdis/Jiy295 |
0.333 |
|
| 2018 |
Woolsey C, Geisbert JB, Matassov D, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Eldridge JH, Mire CE, Geisbert TW. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates. The Journal of Infectious Diseases. PMID 29939296 DOI: 10.1093/Infdis/Jiy293 |
0.421 |
|
| 2018 |
Cross RW, Mire CE, Feldmann H, Geisbert TW. Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews. Drug Discovery. PMID 29725132 DOI: 10.1038/Nrd.2018.73 |
0.312 |
|
| 2018 |
Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, Cheminay C, Volkmann A, Brasel T, Carrion R, Giavedoni LD, Patterson JL, Mire CE, Geisbert TW, Hooper JW, et al. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. Plos One. 13: e0192312. PMID 29462200 DOI: 10.1371/Journal.Pone.0192312 |
0.324 |
|
| 2018 |
Cross RW, Mire CE, Feldmann H, Geisbert TW. Post-exposure treatments for Ebola and Marburg virus infections. Nature Reviews. Drug Discovery. PMID 29375139 DOI: 10.1038/Nrd.2017.251 |
0.383 |
|
| 2017 |
Daaboul GG, Freedman DS, Scherr SM, Carter E, Rosca A, Bernstein D, Mire CE, Agans KN, Hoenen T, Geisbert TW, Ünlü MS, Connor JH. Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses. Plos One. 12: e0179728. PMID 28651016 DOI: 10.1371/Journal.Pone.0179728 |
0.34 |
|
| 2017 |
Mire CE, Geisbert JB, Borisevich V, Fenton KA, Agans KN, Flyak AI, Deer DJ, Steinkellner H, Bohorov O, Bohorova N, Goodman C, Hiatt A, Kim DH, Pauly MH, Velasco J, et al. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9. PMID 28381540 DOI: 10.1126/Scitranslmed.Aai8711 |
0.407 |
|
| 2017 |
Scherr SM, Freedman DS, Agans KN, Rosca A, Carter E, Kuroda M, Fawcett HE, Mire CE, Geisbert TW, Ünlü MS, Connor JH. Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses. Lab On a Chip. PMID 28194457 DOI: 10.1039/C6Lc01528J |
0.342 |
|
| 2016 |
Olsen ME, Filone CM, Rozelle D, Mire CE, Agans KN, Hensley L, Connor JH. Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication. Mbio. 7. PMID 27460797 DOI: 10.1128/Mbio.00882-16 |
0.371 |
|
| 2016 |
Shabman RS, Shrivastava S, Tsibane T, Attie O, Jayaprakash A, Mire CE, Dilley KE, Puri V, Stockwell TB, Geisbert TW, Sachidanandam R, Basler CF. Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell Line. Msphere. 1. PMID 27303702 DOI: 10.1128/mSphere.00070-15 |
0.422 |
|
| 2016 |
Mire CE, Geisbert TW, Feldmann H, Marzi A. Ebola Virus Vaccines - reality or fiction? Expert Review of Vaccines. PMID 27078187 DOI: 10.1080/14760584.2016.1178068 |
0.345 |
|
| 2016 |
Whitt MA, Geisbert TW, Mire CE. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses. Methods in Molecular Biology (Clifton, N.J.). 1403: 295-311. PMID 27076138 DOI: 10.1007/978-1-4939-3387-7_16 |
0.649 |
|
| 2016 |
Pécheur EI, Borisevich V, Halfmann P, Morrey JD, Smee DF, Prichard M, Mire CE, Kawaoka Y, Geisbert TW, Polyak SJ. The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses. Journal of Virology. PMID 26739045 DOI: 10.1128/Jvi.02077-15 |
0.429 |
|
| 2016 |
Satterfield BA, Geisbert TW, Mire CE. Inhibition of the host antiviral response by Nipah virus: Current understanding and future perspectives Future Virology. 11: 331-344. DOI: 10.2217/Fvl-2016-0027 |
0.435 |
|
| 2015 |
Pinsky BA, Sahoo MK, Sandlund J, Kleman M, Kulkarni M, Grufman P, Nygren M, Kwiatkowski R, Baron EJ, Tenover F, Denison B, Higuchi R, Van Atta R, Beer NR, Carrillo AC, ... ... Mire CE, et al. Correction: Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus. Plos One. 10: e0145896. PMID 26690909 DOI: 10.1371/Journal.Pone.0145896 |
0.36 |
|
| 2015 |
Pattabhi S, Wilkins CR, Dong R, Knoll ML, Posakony J, Kaiser S, Mire CE, Wang ML, Ireton RC, Geisbert TW, Bedard KM, Iadonato SP, Loo YM, Gale M. Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway. Journal of Virology. PMID 26676770 DOI: 10.1128/Jvi.02202-15 |
0.422 |
|
| 2015 |
Matassov D, Marzi A, Latham T, Xu R, Ota-Setlik A, Feldmann F, Geisbert JB, Mire CE, Hamm S, Nowak B, Egan MA, Geisbert TW, Eldridge JH, Feldmann H, Clarke DK. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. The Journal of Infectious Diseases. 212: S443-51. PMID 26109675 DOI: 10.1093/Infdis/Jiv316 |
0.455 |
|
| 2015 |
Satterfield BA, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, Mire CE. The immunomodulating V and W proteins of Nipah virus determine disease course. Nature Communications. 6: 7483. PMID 26105519 DOI: 10.1038/Ncomms8483 |
0.369 |
|
| 2015 |
Mire CE, Geisbert JB, Versteeg KM, Mamaeva N, Agans KN, Geisbert TW, Connor JH. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs. The Journal of Infectious Diseases. 212: S384-8. PMID 25957964 DOI: 10.1093/Infdis/Jiv126 |
0.365 |
|
| 2015 |
Thi EP, Mire CE, Lee AC, Geisbert JB, Zhou JZ, Agans KN, Snead NM, Deer DJ, Barnard TR, Fenton KA, MacLachlan I, Geisbert TW. Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates. Nature. 521: 362-5. PMID 25901685 DOI: 10.1038/Nature14442 |
0.329 |
|
| 2015 |
Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Plos Neglected Tropical Diseases. 9: e0003736. PMID 25884628 DOI: 10.1371/Journal.Pntd.0003736 |
0.38 |
|
| 2014 |
Thi EP, Mire CE, Ursic-Bedoya R, Geisbert JB, Lee AC, Agans KN, Robbins M, Deer DJ, Fenton KA, MacLachlan I, Geisbert TW. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Science Translational Medicine. 6: 250ra116. PMID 25143366 DOI: 10.1126/Scitranslmed.3009706 |
0.358 |
|
| 2014 |
Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science Translational Medicine. 6: 242ra82. PMID 24964990 DOI: 10.1126/Scitranslmed.3008929 |
0.373 |
|
| 2014 |
Mire CE, Geisbert JB, Agans KN, Satterfield BA, Versteeg KM, Fritz EA, Feldmann H, Hensley LE, Geisbert TW. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. Plos One. 9: e94355. PMID 24759889 DOI: 10.1371/Journal.Pone.0094355 |
0.352 |
|
| 2014 |
Mire CE, Geisbert JB, Agans KN, Feng YR, Fenton KA, Bossart KN, Yan L, Chan YP, Broder CC, Geisbert TW. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. Journal of Virology. 88: 4624-31. PMID 24522928 DOI: 10.1128/Jvi.00005-14 |
0.365 |
|
| 2014 |
Mire CE, Geisbert TW. Vaccines and antivirals for filoviruses Biology and Pathogenesis of Rhabdo- and Filoviruses. 587-620. DOI: 10.1142/9789814635349_0022 |
0.438 |
|
| 2014 |
Mire CE, Geisbert TW. Viral-vectored vaccines to control pathogenic filoviruses Novel Technologies For Vaccine Development. 33-60. DOI: 10.1007/978-3-7091-1818-4_2 |
0.395 |
|
| 2013 |
Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease. Virology Journal. 10: 353. PMID 24330654 DOI: 10.1186/1743-422X-10-353 |
0.612 |
|
| 2013 |
Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. Mutual antagonism between the ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome Cell Host and Microbe. 14: 74-84. PMID 23870315 DOI: 10.1016/J.Chom.2013.06.010 |
0.416 |
|
| 2012 |
Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. Plos Neglected Tropical Diseases. 6: e1567. PMID 22448291 DOI: 10.1371/Journal.Pntd.0001567 |
0.347 |
|
| 2011 |
Whitt MA, Mire CE. Utilization of fluorescently-labeled tetracysteine-tagged proteins to study virus entry by live cell microscopy. Methods (San Diego, Calif.). 55: 127-36. PMID 21939769 DOI: 10.1016/J.Ymeth.2011.09.002 |
0.666 |
|
| 2011 |
Mire CE, Whitt MA. The protease-sensitive loop of the vesicular stomatitis virus matrix protein is involved in virus assembly and protein translation. Virology. 416: 16-25. PMID 21596416 DOI: 10.1016/J.Virol.2011.04.013 |
0.654 |
|
| 2010 |
Mire CE, White JM, Whitt MA. A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. Plos Pathogens. 6: e1000994. PMID 20657818 DOI: 10.1371/Journal.Ppat.1000994 |
0.614 |
|
| 2009 |
Mire CE, Dube D, Delos SE, White JM, Whitt MA. Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. Journal of Virology. 83: 12139-50. PMID 19776119 DOI: 10.1128/Jvi.00955-09 |
0.628 |
|
| Show low-probability matches. |